Review
Published on 03 Feb 2023
Protein arginine methyltransferases in renal development, injury, repair, and fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1123415
- 2,423 views
- 1 citation
Type at least 3 characters
592 articles
Articles
Review
Published on 30 Jan 2023
Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1103062
- 6,499 views
- 15 citations
Original Research
Published on 17 Jan 2023
Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1082281
- 4,394 views
- 5 citations
Original Research
Published on 13 Jan 2023
Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1031790
- 2,330 views
- 3 citations
Original Research
Published on 09 Jan 2023
Prophylactic doxazosin reduces urinary retention and promotes recovery after total joint arthroplasty: A randomized controlled trial
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1016203
- 2,051 views
- 1 citation
Original Research
Published on 06 Jan 2023
Grape seed proanthocyanidin extract targets p66Shc to regulate mitochondrial biogenesis and dynamics in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1035755
- 3,310 views
- 4 citations
Original Research
Published on 30 Dec 2022
Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1069810
- 4,342 views
- 5 citations
Correction
Published on 22 Dec 2022
Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1074294
- 2,117 views
- 4 citations
Original Research
Published on 20 Dec 2022
Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.992597
- 3,777 views
- 2 citations
Original Research
Published on 07 Dec 2022
Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1077047
- 1,708 views
Original Research
Published on 01 Dec 2022
Inhibition of calpain9 attenuates peritoneal dialysis-related peritoneal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.962770
- 2,320 views
- 4 citations
Original Research
Published on 29 Nov 2022
Integration of transcriptomics and metabolomics reveals the molecular mechanisms underlying the effect of nafamostat mesylate on rhabdomyolysis-induced acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.931670
- 4,172 views
- 3 citations
Editorial
Published on 28 Nov 2022
Editorial: Applications of herbal medicine to control chronic kidney disease: Volume II
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1086049
- 1,867 views
- 1 citation
Original Research
Published on 25 Nov 2022
Yi-Shen-Hua-Shi granules inhibit diabetic nephropathy by ameliorating podocyte injury induced by macrophage-derived exosomes
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.962606
- 5,255 views
- 10 citations
Original Research
Published on 24 Nov 2022
Analysis of a machine learning–based risk stratification scheme for acute kidney injury in vancomycin
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1027230
- 2,385 views
- 1 citation
Systematic Review
Published on 24 Nov 2022
Cardiovascular and renal outcomes with sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus: A system review and network meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.986186
- 5,743 views
- 3 citations